# Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers

> **NCT00711074** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AZD5672

## Key facts

- **NCT ID:** NCT00711074
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2009-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711074, "Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00711074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*